Q1 2025 ICON PLC Earnings Call Transcript
Key Points
- Icon PLC (ICLR) reported better-than-expected adjusted EBITDA margin performance of 19.5% for Q1 2025, demonstrating effective cost control and resource alignment.
- The company has seen a significant increase in overall opportunities in the Biotech segment, with a modest uptick in win rates for projects that reached decision.
- Icon PLC (ICLR) continues to generate momentum from recent strategic partnerships, particularly in the mid-sized Pharma segment.
- The company has launched two new AI-enabled tools, iSubmit and SmartDraft, to enhance operational efficiencies and accelerate clinical trials.
- Icon PLC (ICLR) executed $250 million in share repurchases during Q1 2025, reflecting a commitment to returning capital to shareholders.
- Icon PLC (ICLR) experienced elevated levels of cancellations in Q1 2025, similar to Q4 2024, impacting overall performance in bookings.
- The company reported a year-on-year revenue decrease of 4.3% in Q1 2025, with a constant currency decline of 3.2%.
- Adjusted gross margin for Q1 2025 was 28.2%, down from 29.9% in the same period last year.
- The book-to-bill ratio decreased to 1.01 times in Q1 2025, reflecting challenges in converting opportunities into contracts.
- Icon PLC (ICLR) updated its full-year guidance to account for increased cancellations and the removal of next-generation COVID trials, impacting expected revenue.
Good day and thank you for standing by. Welcome to the ICON PLC Q1 2025 earnings conference call. (Operator Instructions) Please be advised today's conference is being recorded.
I'd now like to hand the conference over to your first speaker today, Kate Haven. Please go ahead.
Good day and thank you for joining us on this call covering the quarter ended March 31, 2025. Also on the call today, we have our CEO, Dr. Steve Cutler; our CFO, Nigel Clerkin; and our COO, Barry Balfe. I would like to note that this call is webcast and that there are slides available to download on our website to accompany today's call.
Certain statements in today's call will be forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with the company's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

